Accordingly, selective inhibition of CCR2+ macrophages was shown to inhibit left ventricular hypertrophy, ameliorate diastolic function, and reduce cardiac interstitial fibrosis and inflammation in HFpEF [112]. Here, CCR2 is linked to Interstitial cardiac fibrosis.